Currie Mark G 4
4 · Cyclerion Therapeutics, Inc. · Filed Dec 30, 2020
Insider Transaction Report
Form 4
Currie Mark G
President
Transactions
- Sale
Common Stock
2020-12-28$3.01/sh−20,107$60,522→ 251,648 total
Footnotes (2)
- [F1]The proceeds from the sale are intended to cover income taxes arising out of prior stock option exercises, including those in which the reporting person held the underlying shares.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.94 to $3.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.